Senior Medical & Clinical Affairs (MACA) Operations Specialist
Sirtex
Summary
Sirtex Medical Limited is a global medical device company specializing in targeted radiation therapies for liver cancer. Founded in 1997 in Australia, the company has established itself as a leader in minimally invasive oncology treatments with its flagship product, SIR-Spheres Y-90 resin microspheres. This innovative medical device delivers selective internal radiation therapy (SIRT) for inoperable liver tumors, providing a treatment option for patients with primary liver cancer and metastatic colorectal cancer. The company operates globally with offices and production facilities in the United States, Australia, Germany, and Singapore, serving over 1,300 medical centers across more than 50 countries. Sirtex has supplied more than 100,000 doses of its SIR-Spheres microspheres, which work by delivering high-energy beta radiation directly to liver tumors through the hepatic artery, sparing healthy tissue while achieving radiation doses up to 40 times higher than conventional radiotherapy. The company was acquired by China Grand Pharmaceutical and Healthcare Holdings Ltd. and CDH Genetech in 2018 and is currently led by CEO Kevin R. Smith. Sirtex continues to advance cancer treatment through research collaborations and strategic partnerships focused on improving patient outcomes in oncology.
Job description
Key Responsibilities
- Serve as the primary operations and administrative lead for Medical and Clinical Affairs, ensuring efficient execution of department programs, processes, and initiatives.
- Manage the end-to-end administration of educational grants, fellowship grants, and investigator-sponsored research (ISR) programs, including application intake, review coordination, contract administration, budget tracking, reconciliation, and project closeout.
- Coordinate and support cross-functional governance committees, facilitating grant and research proposal reviews, documentation, communications, and decision-making processes.
- Partner with Medical Affairs leadership to track project progress, monitor risks, manage deliverables, and provide regular status updates and operational reporting to senior leadership.
- Lead routine presentations and progress reports to senior leadership team to guide strategic decision-making.
- Oversee contract management and agreements for physicians and clinical studies.
- Manage departmental financial operations, including budget planning, forecasting, accruals, invoice processing, expense tracking, contract management, and vendor oversight.
- Support physician training, evaluation, certification, and proctoring programs by coordinating program requirements, documentation, scheduling, reimbursement processes, training materials, and learning management system updates.
- Build and maintain strong relationships with internal stakeholders, healthcare professionals, investigators, study teams, vendors, and cross-functional partners to ensure successful execution of Medical Affairs and Clinical Affairs initiatives.
- Provide operational support for a variety of Medical Affairs activities, including advisory boards, fellowship programs, research studies, publications, educational programs, controlled document management, adverse event reporting and other strategic projects.
Qualifications
- Bachelor's degree in Life Sciences, Business, Healthcare Administration, or a related field.
- 5+ years of experience in operations, project coordination, or program management.
- Strong organizational and project management skills with the ability to balance competing priorities.
- High visibility and high volume external and internal customer-facing role requiring strong consistent engagement and communication.
- Excellent communication and relationship-building skills.
- Strong attention to detail and a commitment to delivering high-quality work.
- Ability to collaborate effectively with cross-functional teams and external partners.
- Experience in Medical Affairs, Clinical Research, Healthcare, Pharmaceutical, Biotechnology, or Medical Device environments is preferred.
Requirements
- Bachelor's degree in Life Sciences, Business, Healthcare Administration, or a related field.
- 5+ years of experience in operations, project coordination, or program management.
- Strong organizational and project management skills with the ability to balance competing priorities.
- High visibility and high volume external and internal customer-facing role requiring strong consistent engagement and communication.
- Excellent communication and relationship-building skills.
- Strong attention to detail and a commitment to delivering high-quality work.
- Ability to collaborate effectively with cross-functional teams and external partners.
- Experience in Medical Affairs, Clinical Research, Healthcare, Pharmaceutical, Biotechnology, or Medical Device environments is preferred.
Benefits
- 401(k) Matching
- Medical, Dental & Vision
- Paid Sick Time
- Paid Vacation Time
- Incentive Program
- Flexible Work Arrangements
- Career Development
- Training Opportunities
Company overview
Sirtex Medical Limited is a global medical device company specializing in targeted radiation therapies for liver cancer. Founded in 1997 in Australia, the company has established itself as a leader in minimally invasive oncology treatments with its flagship product, SIR-Spheres Y-90 resin microspheres. This innovative medical device delivers selective internal radiation therapy (SIRT) for inoperable liver tumors, providing a treatment option for patients with primary liver cancer and metastatic colorectal cancer. The company operates globally with offices and production facilities in the United States, Australia, Germany, and Singapore, serving over 1,300 medical centers across more than 50 countries. Sirtex has supplied more than 100,000 doses of its SIR-Spheres microspheres, which work by delivering high-energy beta radiation directly to liver tumors through the hepatic artery, sparing healthy tissue while achieving radiation doses up to 40 times higher than conventional radiotherapy. The company was acquired by China Grand Pharmaceutical and Healthcare Holdings Ltd. and CDH Genetech in 2018 and is currently led by CEO Kevin R. Smith. Sirtex continues to advance cancer treatment through research collaborations and strategic partnerships focused on improving patient outcomes in oncology.